Top Story

Gardasil 9 HPV vaccine also safe, effective in younger boys, girls

June 30, 2015

Recent study data showed that Gardasil 9 HPV vaccine also is safe and effective in boys and girls aged 9 to 15 years, advancing previous research that found similar results for girls and young women aged 16 to 26 years.

“This study represents the first analysis of 9-valent HPV vaccine immunogenicity in girls and boys 9 to 15 years of age, the primary target population for immunoprophylaxis to prevent HPV-related pre-cancers and cancers of the anogenital tract,” researcher Pierre Van Damme, MD, PhD, of the Center for the Evaluation of Vaccination, University of Antwerp, and colleagues wrote. “The antibody responses in 9- to 15-year-old boys and girls was shown to be noninferior to those observed in 16- to 26-year-old young women.”

Medicare fraud takedown: A closer look Health Care Legislative and Regulatory Update

Medicare fraud takedown: A closer look

June 30, 2015
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
VIDEO: Daniel Kuritzkes, MD, details approaches aimed at HIV eradication At IssueVideo

VIDEO: Daniel Kuritzkes, MD, details approaches aimed at HIV eradication

June 30, 2015
With more than 25 years of experience investigating HIV, Daniel Kuritzkes, MD, chief of the division of infectious diseases at Brigham & Women’s Hospital and…
VIDEO: ‘Cure’ no longer a ‘four-letter word’ in AIDS research At IssueVideo

VIDEO: ‘Cure’ no longer a ‘four-letter word’ in AIDS research

June 30, 2015
Joseph Eron, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the highlights of recent developments of researchers to develop…
Burden of collecting data for MRSA, S. aureus infections is 'extensive' Meeting News CoveragePerspective

Burden of collecting data for MRSA, S. aureus infections is 'extensive'

June 30, 2015
The burden of collecting and analyzing infection data in hospitals to comply with the reporting requirements of federal health agencies is “extensive,”…
More News Headlines »
CME
HCV VOICE

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
At Issue Video
VIDEO: ‘Cure’ no longer a ‘four-letter word’ in AIDS research

VIDEO: ‘Cure’ no longer a ‘four-letter word’ in AIDS research

June 30, 2015
Joseph Eron, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the…
More »
CME
Infectious Disease Case Consults

The Patient with Protozoan Illness

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with protozoan illness.
More »
morganatic-roan
morganatic-roan